JNJ-26854165 (Serdemetan): HDM2 Ubiquitin Ligase Antagoni...
2026-01-20
JNJ-26854165 (Serdemetan) is a potent HDM2 ubiquitin ligase antagonist and p53 activator. It induces anti-proliferative and apoptosis effects in cancer cell models, providing a validated tool for p53 pathway research. APExBIO supplies Serdemetan as SKU A4204 for advanced cancer studies.